We are live on ! Find out more
BIM

BlackRock Investment Management Portfolio holdings

AUM $86.4B
1-Year Est. Return 28.54%
This Fund
S&P 500
This Quarter Est. Return
+15.87%
1 Year Est. Return
+28.54%
3 Year Est. Return
+50.87%
5 Year Est. Return
10 Year Est. Return
AUM
$81.4B
AUM Growth
+$2.32B
Cap. Flow
-$2.14B
Cap. Flow %
-2.64%
Top 10 Hldgs %
14.09%
Holding
4,126
New
79
Increased
1,674
Reduced
1,700
Closed
176

Top Sells

Rank Stock Value
1
TTE icon
TotalEnergies
TTE
+$1.28B
2
INTC icon
Intel
INTC
+$164M
3
EMC
EMC CORPORATION
EMC
+$111M
4
MCD icon
McDonald's
MCD
+$90.2M
5
AGN
Allergan plc
AGN
+$88.1M

Sector Composition

Rank Sector Weight
1 Financials 15.37%
2 Healthcare 14.6%
3 Technology 13.59%
4 Industrials 9.57%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKY icon
3401
Champion Homes
SKY
$5.23B
$17K ﹤0.01%
1,210
FBMS
3402
DELISTED
The First Bancshares, Inc.
FBMS
$17K ﹤0.01%
864
PMD
3403
DELISTED
Psychemedics Corporation
PMD
$17K ﹤0.01%
877
ITI
3404
DELISTED
Iteris, Inc.
ITI
$17K ﹤0.01%
4,579
-242
-5% -$841
IMBI
3405
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$17K ﹤0.01%
756
-70
-8% -$1.33K
DRNA
3406
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$17K ﹤0.01%
2,889
+307
+12% +$1.08K
YUME
3407
DELISTED
YuMe, Inc.
YUME
$17K ﹤0.01%
4,165
+316
+8% +$1.14K
GI
3408
DELISTED
EndoChoice Holdings, Inc.
GI
$17K ﹤0.01%
2,166
ACW
3409
DELISTED
Accuride Corp
ACW
$17K ﹤0.01%
6,785
ABEO icon
3410
Abeona Therapeutics
ABEO
$361M
$16K ﹤0.01%
106
CBFV icon
3411
CB Financial Services
CBFV
$190M
$16K ﹤0.01%
665
CRMD icon
3412
CorMedix
CRMD
$639M
$16K ﹤0.01%
1,263
+85
+7% +$795
EYPT icon
3413
EyePoint Inc
EYPT
$1.16B
$16K ﹤0.01%
532
+14
+3% +$508
KURA icon
3414
Kura Oncology
KURA
$896M
$16K ﹤0.01%
2,529
PEBK icon
3415
Peoples Bancorp of North Carolina
PEBK
$237M
$16K ﹤0.01%
859
SLP icon
3416
Simulations Plus
SLP
$370M
$16K ﹤0.01%
1,852
STRR
3417
DELISTED
Star Equity Holdings
STRR
$16K ﹤0.01%
64
TSBK icon
3418
Timberland Bancorp
TSBK
$361M
$16K ﹤0.01%
1,038
ZYNE
3419
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$16K ﹤0.01%
1,211
SES
3420
DELISTED
Synthesis Energy Systems Inc.
SES
$16K ﹤0.01%
201
+16
+9% +$1.18K
CFRX
3421
DELISTED
ContraFect Corporation
CFRX
$16K ﹤0.01%
8
+2
+33% +$3.93K
ACFC
3422
DELISTED
Atlantic Coast Financial Corporation
ACFC
$16K ﹤0.01%
2,478
FSBK
3423
DELISTED
First South Bancorp Inc/VA
FSBK
$16K ﹤0.01%
1,563
CLBH
3424
DELISTED
Carolina Bank Holdings Inc
CLBH
$16K ﹤0.01%
795
+98
+14% +$1.85K
IIP
3425
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$16K ﹤0.01%
9,630

Similar funds

BlackRock Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, BlackRock Investment Management held 4,126 positions worth $81.4B, up 2.9% from $79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Investment Management's Q3 2016 filing shows 79 new, 1,674 increased, 1,700 reduced and 176 closed positions. Its largest new stake was Fortive: 900,865 shares worth $28.9M. The largest sale was TotalEnergies, an estimated $1.28B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • BlackRock Investment Management's largest Q3 2016 buy was Fortive: 900,865 shares worth $28.9M.
  • BlackRock Investment Management added most to Alexion Pharmaceuticals in Q3 2016, an estimated $185M increase.
  • BlackRock Investment Management's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $1.28B.
  • BlackRock Investment Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $111M.
  • BlackRock Investment Management's ten largest holdings make up 14% of its $81.4B portfolio in Q3 2016.
  • BlackRock Investment Management opened 79 new positions and closed 176 in Q3 2016.
  • BlackRock Investment Management's portfolio value rose 2.9% quarter-over-quarter to $81.4B.

Based on BlackRock Investment Management's 13F filing for Q3 2016, filed 8 Nov 2016.